Market closed
Becton Dickinson/$BDX
Becton, Dickinson shares are trading higher after the company announced FDA clearance and the launch of its Phasix™ ST Umbilical Hernia Patch.
9 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Becton Dickinson
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Ticker
$BDX
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
74,000
Website
Becton Dickinson Metrics
BasicAdvanced
$57B
33.64
$5.94
0.43
$3.98
2.08%
Price and volume
Market cap
$57B
Beta
0.43
52-week high
$251.99
52-week low
$193.03
Average daily volume
2.4M
Dividend rate
$3.98
Financial strength
Current ratio
1.13
Quick ratio
0.439
Long term debt to equity
69.193
Total debt to equity
74.422
Dividend payout ratio (TTM)
65.26%
Interest coverage (TTM)
5.09%
Management effectiveness
Return on assets (TTM)
3.70%
Return on equity (TTM)
6.83%
Valuation
Price to earnings (TTM)
33.64
Price to revenue (TTM)
2.805
Price to book
2.3
Price to tangible book (TTM)
-4.98
Price to free cash flow (TTM)
19.716
Dividend yield (TTM)
1.99%
Forward dividend yield
2.08%
Growth
Revenue change (TTM)
5.89%
Earnings per share change (TTM)
41.25%
3-year revenue growth (CAGR)
3.65%
3-year earnings per share growth (CAGR)
1.05%
3-year dividend per share growth (CAGR)
5.00%
What the Analysts think about Becton Dickinson
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Becton Dickinson stock.
Becton Dickinson Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Becton Dickinson Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Becton Dickinson News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Becton Dickinson stock?
Becton Dickinson (BDX) has a market cap of $57B as of April 24, 2025.
What is the P/E ratio for Becton Dickinson stock?
The price to earnings (P/E) ratio for Becton Dickinson (BDX) stock is 33.64 as of April 24, 2025.
Does Becton Dickinson stock pay dividends?
Yes, the Becton Dickinson (BDX) stock pays dividends to shareholders. As of April 24, 2025, the dividend rate is $3.98 and the yield is 2.08%. Becton Dickinson has a payout ratio of 65.26% on a trailing twelve-month basis.
When is the next Becton Dickinson dividend payment date?
The next Becton Dickinson (BDX) dividend payment date is unconfirmed.
What is the beta indicator for Becton Dickinson?
Becton Dickinson (BDX) has a beta rating of 0.43. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.